150560-46-6

Basic information

• Product Name: Methyl [2-(2-Diphenylmethyloxazol-4-yl)methyl-1,2,3,4-tetrahydronaphthalen-5-yloxy]acetate
• Synonyms: Methyl [2-(2-Diphenylmethyloxazol-4-yl)methyl-1,2,3,4-tetrahydronaphthalen-5-yloxy]acetate
• CAS NO: 150560-46-6
• Molecular Weight: 467.565
• Mol File: 150560-46-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Methyl [2-(2-Diphenylmethyloxazol-4-yl)methyl-1,2,3,4-tetrahydronaphthalen-5-yloxy]acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl [2-(2-Diphenylmethyloxazol-4-yl)methyl-1,2,3,4-tetrahydronaphthalen-5-yloxy]acetate(150560-46-6)
• EPA Substance Registry System: Methyl [2-(2-Diphenylmethyloxazol-4-yl)methyl-1,2,3,4-tetrahydronaphthalen-5-yloxy]acetate(150560-46-6)

Safety Data

• Hazardous Substances Data: 150560-46-6(Hazardous Substances Data)

Upstream product

• 150560-05-7 2-Bromomethylcarbonylmethyl-5-tert-butylcarbonyloxy-1,2,3,4-tetrahydronaphthalene 
• 150560-04-6 (5-tert-butylcarbonyloxy-1,2,3,4-tetrahydronaphthalen-2-yl)acetic acid 
• 150559-98-1 2-Carboxymethyl-5-hydroxy-1,2,3,4-tetrahydronaphthalene 
• 1716-11-6 diphenylacetic acid sodium salt 
• 96-32-2 bromoacetic acid methyl ester 
• 150560-07-9 2-(2-Diphenylmethyloxazol-4-yl)methyl-5-hydroxy-1,2,3,4-tetrahydronaphthalene 

Relevant articles and documents

Novel nonprostanoid prostacyclin (PGI2) mimetics with heterocyclic moiety

Structural modification of [2-(2-benzhydryloxyiminopentyl)-1,2,3,4-tetrahydro-5-naphthyloxy]acetic acid (4), previously identified as a PGI2 agonist without a PG skeleton, was examined. Conversion of the oxime moiety in 4 to the pyrazole led to [2-(4-benzhydrylpylazoyl)methyl-1,2,3,4-tetrahydro-5-naphthyloxy]acetic acid (34) which strongly inhibited ADP-induced aggregation of human platelets in vitro.